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Abstract: Goupiolones A and B are unique phenolic compounds 
with significant DNA-damaging activity. In this study, the structure of 
goupiolone B was revised on the basis of DFT calculations of the 13C 
NMR chemical shifts and biosynthetic considerations. The 
dibenzobicyclo[3.2.2]nonane skeleton of the revised structure 
suggested that goupiolone B was produced by oxidative coupling 
between catechol and goupiolone A, which was strongly supported 
by this biomimetic synthesis. Furthermore, the racemization of 
goupiolone B was observed during the examination for the chiral 
separation of its racemic mixture. A plausible racemization 
mechanism involving α-ketol rearrangement was also proposed. 
Goupiolones A (1) and B (2) are unique phenolic 
compounds isolated from the leaves of Goupia glabra 
(Goupiaceae), and reported to show significant toxicity against a 
panel of DNA damage-checkpoint defective yeast mutants 
(Figure 1).[1] Since 1 and 2 behave as genotoxins that are 
stronger than the antineoplastic agent doxorubicin, they are 
candidates for anticancer drugs.[1] Goupiolone A (1) is a 
benzotropolone derivative[1,2] and presumed to be produced from 
catechol (3) and ethyl gallate (4) by oxidative coupling via a 
benzobicyclo[3.2.1]octane-type intermediate (Scheme 1). Other 
benzotropolone derivatives from natural sources, such as 
purpurogallin glycosides,[3] theaflavins,[4] fomentariol,[5] 
aurantricholone,[6] and crocipodin,[7] are also produced by the 
coupling between catechol and pyrogallol derivatives.[8] On the 
other hand, goupiolone B (2) was reported as a Diels–Alder 
adduct between a tropolone and a naphthalene derivative.[1] 
However, the proposed precursor, that is 1,2,3,4-
naphthalenetetraol, has not yet been found in nature. In addition, 
the reported spectroscopic data of 2 include several problems. 
For example, the 13C NMR signal of the β-position in the α,β-
unsaturated carbonyl is normally observed lower field, such as 
at 150.9 ppm for 2-cyclohexen-1-one.[9] However, the signal at 
118.1 ppm was assigned as the β-position (C-6) of 2.[1] 
Moreover, the assignment of the 13C NMR chemical shifts of the 
1,2,3,4-tetrahydroxybenzene moiety in 2 were inappropriate (C-
5'': δ 145.1; C-6'': δ 152.5; C-7'': δ 142.7; C-8'': δ 140.5; C-9'': δ 
144.0; C-10'': δ 137.0). In this study, we reinvestigated the 
structure of goupiolone B using computational calculations and 
biosynthetic considerations and proposed the revised structure 5. 
Furthermore, the structure was confirmed via biomimetic 
synthesis.  
We speculated that goupiolone B is biosynthetically 
derived from goupiolone A (1) and reinvestigated its structure 
on the basis of the reported 1H and 13C NMR data along with 
biosynthetic considerations. As a result, we constructed the 
more reasonable structure 5 with a dibenzobicyclo[3.2.2]nonane 
skeleton (Figure 1). The biosynthesis of 5 could be explained as 
follows: Goupiolone A (1) is apparently produced by the 
oxidative condensation between catechol-quinone (3a) derived 
from catechol (3) and ethyl gallate (4) through a 
benzobicyclo[3.2.1]octane-type intermediate. Then, a series of 
intermolecular 1,4- and intramolecular 1,2-additions between 3a 
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Figure 2. Correlation plots of experimental 13C NMR chemical shifts 
versus the corresponding calculated data of 2 (a) or 5 (b). 
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Figure 1. Structures of goupiolone A (1) and goupiolone B (2: formerly 
proposed[1]; 5: revised). 





and 1 and the subsequent reduction of o-quinone affords 5 
(Scheme 1). Furthermore, the experimental NMR data of 
goupiolone B was very similar to those of the 
dibenzobicyclo[3.2.2]nonane unit of 6, which is an oxidative 
condensation product of theaflavin (7) and epicatechin (8) 
(Scheme 2).[11] The structural similarity strongly supported the 
biosynthetic mechanism of 5.[11] The validity of structure 5 was 
confirmed by DFT calculations for the 13C NMR chemical shifts 
of 2 and 5,[10] followed by comparison with the reported data. As 
shown in Figure 2, the correlation between experimental and 
calculated data for 2 was very low (R2 = 0.8318), whereas the 
calculated data for 5 was in good agreement with the 
experimental data (R2 = 0.9980). On the basis of these 
considerations, we performed the biomimetic synthesis of 5 from 
3 and 4 via 1. 
Firstly, we synthesized goupiolone A (1). Thus far, there 
have been two reports for the total synthesis of 1; however, 
these methods required many steps [19 steps (2012),[2] 9 steps 
(2017)[12]]. In this study, the non-enzymatic biomimetic method 
developed for theaflavins, black tea pigments with a 
benzotropolone moiety,[13] was applied to the synthesis of 1. 
Catechol (3) was oxidized with the 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) radical in acetone to afford o-quinone (3a); then, ethyl 
gallate (4) was added to give a benzobicyclo[3.2.1]octane-type 
intermediate. Finally, the addition of water to the reaction 
mixture caused ring cleavage, followed by spontaneous 
oxidation and decarboxylation to afford goupiolone A (1) (34% 
from 4) along with a small amount of 5 (1.1% from 4) (Scheme 
3a). The spectroscopic data of synthesized 1 were in full 
agreement with those of natural 1.[1,2] In addition, the 1H and 13C 
NMR data of synthesized 5 were completely consistent with 
those of the natural goupiolone B, except for the 13C NMR 
chemical shift of C-2' (∆δC = 5.7 ppm) (Table 1).[1] The 
previously reported value of C-2' is presumably a typographical 
error. 1H-1H COSY, HSQC, and HMBC spectra of synthesized 5 
were also measured, and the results strongly supported this 
structure. However, several HMBC correlations of the 
synthesized 5 were inconsistent with the reported data for 
goupiolone B (Table 1). This was probably caused by incorrect 
interpretations based on the incorrect structure (2) in the original 
report.[14] There are several steps during the production of 1 from 
3 and 4. (Scheme 1). In this process, 3a derived from 3 can also 
act as an oxidant along with DPPH. In the final step of the 
synthesis of 5, the o-quinone form of 5 is reduced to 5 (Scheme 
1). This reduction process is considered to be coupled with the 
oxidation of 3 or the oxidation steps during the synthesis of 1. 
Enzymatic methods for the synthesis of benzotropolone 
derivatives using polyphenol oxidase or peroxidase are 
known;[7,15] therefore, we also performed the enzymatic 
synthesis of goupiolone A (1). An aqueous solution of catechol 
(3) and ethyl gallate (4) was treated with a Japanese pear 
(Pyrus pyrifolia) fruit homogenate, which has strong polyphenol 
oxidase activity,[15d,16] to afford goupiolone A (1) (71%) along 
with 5 (0.24%) (Scheme 3b). This relatively high yield of 1 is 
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Scheme 1. Proposed biosynthetic pathway of goupiolone B (5) from catechol (3) and ethyl gallate (4) via goupiolone A (1). 
Scheme 3. Synthesis of goupiolones A (1) and B (5) from 3 and 4 using 
DPPH radical (a) or a Japanese pear fruit homogenate (b). 





considered to be attributed to the substrate specificity of 
polyphenol oxidase for 3.  
  To confirm that goupiolone B (5) was produced by 
oxidative coupling between goupiolone A (1) and catechol (3), 
next we examined direct reactions of 1 with 3. Addition of 1 to 
the mixture containing 3a yielded 5 in 7.2% (Scheme 4a). To 
improve the yield, various oxidants were examined. After 
screening with multiple oxidants, (NH4)2Ce(NO3)6 and 
K3[Fe(CN)6] were found to afford 5 from 1 and 3. The addition of 
(NH4)2Ce(NO3)6 to a solution containing 1 and 3 in CH3CN–H2O 
(4:1) afforded 5 in 22% yield (Scheme 4b). Under similar 
conditions, oxidation using K3[Fe(CN)6] afforded 5 in 11% yield. 
The reason for the low yield for 5 is considered to be the other 
oxidation reaction of 1 and further oxidation of 5. These results 
confirmed that 5 was produced from 1 and 3. Therefore, we 
concluded that the correct structure of goupiolone B is 5.  
In this study, goupiolone B (5) was synthesized as a 
racemic mixture. However, natural 5 was optically active ([α]20D 
−40).[1] To determine the absolute structure of natural 5, an 
attempt was made to separate two enantiomers of synthesized 5 
using chiral HPLC. Several conditions were found for the chiral 
separation of racemic 5 in reversed phase and normal phase 
conditions, which afforded two separated peaks (Figures S1, S2). 
However, separated 5 showed no optical rotation and Cotton 
effect in the ECD spectra. In addition, the reanalysis of 
separated 5 using chiral column exhibited two peaks, indicating 
that the racemization of 5 occurs easily. To comprehensively 
investigate the condition, chiral separation was performed at 
three different temperatures (40 °C, 25 °C, and 5 °C) using 
Chiralpak IB N-5 (n-hexane–2-PrOH–TFA; 55:45:0.1) (Figure 
S3). Two peaks were completely separated at a temperature of 
5 °C; however, a saddle-shaped curve was observed between 
two peaks at 40 °C. The experimental results strongly indicated 
the occurrence of racemization of 5 during chiral separation at 
40 °C. A reasonable mechanism for the racemization of 5 
involves α-ketol rearrangement shown in Scheme 5.[17,18] This 
rearrangement had been observed in several natural 
products.[19] Natural 5 may also be a racemic mixture, and its 
optical activity may be attributable to its impurity. However, no 
evidence is currently available. 
In summary, we proposed the correct structure of 
goupiolone B (5), which was assisted by biosynthetic 
considerations. DFT calculations of the 13C NMR chemical shifts 
strongly supported this structure. The biomimetic synthesis of 5 
from catechol (3) and ethyl gallate (4) via goupiolone A (1) 
confirmed the revised structure. Furthermore, the racemization 
of 5 was observed during its chiral separation, indicating that 
natural 5 may also be a racemic mixture. A plausible 
racemization mechanism involving α-ketol rearrangement was 
position
synthesizeda naturalb,e synthesizedc naturald,e synthesizeda naturalb,e
1 194.1 194.1
2 84.3 84.5
3 7.26f 7.26f 143.6 143.6 1, 2, 4, 5, 11 (4J ), 1', 3'' 1, 5, 3''
4 140.5 140.5
5 5.10 (br s) 5.03 (d, 1.3) 49.8 49.8 3, 4, 6, 10, 11, 1', 3'', 4'', 5'' 10, 11, 1', 4'', 5''
6 6.84 (d, 8.1) 6.84 (d, 8.0) 118.2 118.1 1, 5, 8, 10 1, 10






2' 4.24 (m) 4.23 (m) 61.5 67.2 1', 3' 1', 3'





5'' 6.82 (d, 8.1) 6.82 (d, 8.0) 117.4 117.3 2 (4J ), 5, 1'', 3'' 5
6'' 6.77 (d, 8.1) 6.77 (d, 8.0) 114.3 114.3 1'', 2'', 4'' 7, 11, 4''
9-OH 11.72 (s) 8, 9, 10
a  500 MHz, b 300 MHz[1] , c 125 MHz, d 75 MHz[1] , e reassigned based on the structure of 5 ,  f overlapped with
solvent signal
Table 1. 1H and 13C NMR data for goupiolone B (5) (in CDCl3, δ in ppm, J  in Hz)
HMBC (H to C)13C1H












































































proposed. These results indicated that the biosynthetic 
consideration combined with the theoretical calculation of NMR 
data is helpful to accurately elucidate the complicated structure 
of natural products.[20] 
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Which one is real? Goupiolones A and B are unique phenolic compounds with 
significant DNA-damaging activity. In this study, the structure of goupiolone B was revised 
on the basis of DFT calculations of the 13C NMR chemical shifts and biosynthetic 
considerations. The dibenzobicyclo[3.2.2]nonane skeleton of the revised structure 
suggested that goupiolone B is produced by an oxidative coupling between catechol and 
goupiolone A. This revised structure and proposed biosynthetic pathway was strongly 
supported by the biomimetic synthesis.  
